These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11306977)

  • 1. Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils.
    Elsner J; Dulkys Y; Kimmig D; Wells TN; Proudfoot AE; Kapp A
    Int Arch Allergy Immunol; 2001; 124(1-3):227-9. PubMed ID: 11306977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of CC chemokine receptors by AOP-RANTES.
    Elsner J; Mack M; Brühl H; Dulkys Y; Kimmig D; Simmons G; Clapham PR; Schlöndorff D; Kapp A; Wells TN; Proudfoot AE
    J Biol Chem; 2000 Mar; 275(11):7787-94. PubMed ID: 10713092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling.
    Bandeira-Melo C; Sugiyama K; Woods LJ; Phoofolo M; Center DM; Cruikshank WW; Weller PF
    J Immunol; 2002 May; 168(9):4756-63. PubMed ID: 11971026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils.
    Elsner J; Petering H; Kluthe C; Kimmig D; Smolarski R; Ponath P; Kapp A
    Eur J Immunol; 1998 Jul; 28(7):2152-8. PubMed ID: 9692884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CC chemokine receptor antagonist met-RANTES inhibits eosinophil effector functions.
    Elsner J; Petering H; Kimmig D; Wells TN; Proudfoot AE; Kapp A
    Int Arch Allergy Immunol; 1999; 118(2-4):462-5. PubMed ID: 10224475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.
    Elsner J; Höchstetter R; Kimmig D; Kapp A
    Eur J Immunol; 1996 Aug; 26(8):1919-25. PubMed ID: 8765040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
    Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
    J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
    Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
    J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
    Shahabuddin S; Ponath P; Schleimer RP
    J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner.
    Bochner BS; Bickel CA; Taylor ML; MacGlashan DW; Gray PW; Raport CJ; Godiska R
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):527-32. PubMed ID: 10069890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein.
    Tenscher K; Metzner B; Schöpf E; Norgauer J; Czech W
    Blood; 1996 Oct; 88(8):3195-9. PubMed ID: 8874220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3.
    Chvatchko Y; Proudfoot AE; Buser R; Juillard P; Alouani S; Kosco-Vilbois M; Coyle AJ; Nibbs RJ; Graham G; Offord RE; Wells TN
    J Immunol; 2003 Nov; 171(10):5498-506. PubMed ID: 14607956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophil activation by eotaxin--eotaxin primes the production of reactive oxygen species from eosinophils.
    Honda K; Chihara J
    Allergy; 1999 Dec; 54(12):1262-9. PubMed ID: 10688429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human RANTES acts as a receptor antagonist for guinea pig eotaxin in vitro and in vivo.
    Marleau S; Griffiths-Johnson DA; Collins PD; Bakhle YS; Williams TJ; Jose PJ
    J Immunol; 1996 Nov; 157(9):4141-6. PubMed ID: 8892650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells.
    Umland SP; Wan Y; Shortall J; Shah H; Jakway J; Garlisi CG; Tian F; Egan RW; Billah MM
    J Leukoc Biol; 2000 Mar; 67(3):441-7. PubMed ID: 10733106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-3 induces down-regulation of CCR3 protein and mRNA in human eosinophils.
    Dulkys Y; Kluthe C; Buschermöhle T; Barg I; Knöss S; Kapp A; Proudfoot AE; Elsner J
    J Immunol; 2001 Sep; 167(6):3443-53. PubMed ID: 11544337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils.
    Dulkys Y; Schramm G; Kimmig D; Knöss S; Weyergraf A; Kapp A; Elsner J
    J Invest Dermatol; 2001 Apr; 116(4):498-505. PubMed ID: 11286614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors.
    Proudfoot AE; Buser R; Borlat F; Alouani S; Soler D; Offord RE; Schröder JM; Power CA; Wells TN
    J Biol Chem; 1999 Nov; 274(45):32478-85. PubMed ID: 10542293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.